Welcome, Guest. Please login or register.
April 17, 2024, 02:47:51 pm

Login with username, password and session length


Members
  • Total Members: 6307
  • Latest: golfer
Stats
  • Total Posts: 55125
  • Total Topics: 4851
  • Online Today: 57
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 35
Total: 35

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Cities With Better Harm Reduction See Drop in Drug Users’ Hep C Rates  (Read 5060 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Hepatitis C virus (HCV) transmission rates among injection drug users (IDUs) vary widely between Western cities, with differences likely significantly driven by local harm-reduction efforts. Specifically, access to syringe services programs (SSPs) likely helps contain hep C transmission among local IDU populations. 

Publishing their findings in Clinical Infectious Diseases, researchers studied population-based cohort data from HCV-negative IDUs in Boston, Baltimore, San Francisco, Montreal, Amsterdam, Sydney and Melbourne covering 1985 to 2011.

Read more...
https://www.hepmag.com/article/cities-better-harm-reduction-see-drop-drug-users-hep-c-rates

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.